Skip to main content
Premium Trial:

Request an Annual Quote

Pyrosequencing, University of Geneva Unite to Develop Down Syndrome Diagnostic

NEW YORK, Aug. 29 – Pyrosequencing and the University of Geneva have partnered to develop a diagnostic test for Down Syndrome, the company announced on Wednesday.

The molecular diagnostics business unit of Pyrosequencing will sponsor the university's research to analyze genes and develop a test based on the company's technology. Pyrosequencing said it had secured exclusive access to the intellectual property underlying the University of Geneva’s method to detect the gene.

Financial details of the agreement were not disclosed.

"A rapid, accurate and cost-effective diagnostic test for Down Syndrome has been the focus of several clinical research efforts around the world," Stylianos Antonarakis, director of the division of medical genetics at the University of Geneva, said in a statement. "We will use Pyrosequencing’s technology to develop novel diagnostic tests for this prevalent genetic disease with the ultimate goal of improving health care."

While an accurate test currently exists to screen for chromosomes linked to Down Syndrome--a condition appears in one out of 700 live births in the US each year--it is labor intensive and time consuming, according to Pyrosequencing.

On Tuesday, Pyrosequencing, based in Uppsala, Sweden, received US patents covering DNA sequencing based on real-time pyrophosphate detection.

In May, the company, which develops, manufactures, and sells DNA sequencing systems for applied genetic analysis, also  won a patent for assessing cardiovascular conditions such as myocardial infarction.

The Scan

Panel Recommends Pfizer-BioNTech Vaccine for Kids

CNN reports that the US Food and Drug Administration advisory panel has voted in favor of authorizing the Pfizer-BioNTech SARS-CoV-2 vaccine for children between 5 and 11 years old.

Sharing How to Make It

Merck had granted a royalty-free license for its COVID-19 treatment to the Medicines Patent Pool, according to the New York Times.

Bring it Back In

Bloomberg reports that a genetic analysis has tied a cluster of melioidosis cases in the US to a now-recalled aromatherapy spray.

Nucleic Acids Research Papers on SomaMutDB, VThunter, SCovid Databases

In Nucleic Acids Research this week: database of somatic mutations in normal tissue, viral receptor-related expression signatures, and more.